Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma
-
Published:2024-02
Issue:2
Volume:9
Page:102248
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Geurts Y.M.ORCID, Neppelenbroek S.I.M.ORCID, Aleman B.M.P.ORCID, Janus C.P.M., Krol A.D.G.ORCID, van Spronsen D.J., Plattel W.J., Roesink J.M.ORCID, Verschueren K.M.S.ORCID, Zijlstra J.M., Koene H.R., Nijziel M.R.ORCID, Schimmel E.C., de Jongh E.ORCID, Ong F., te Boome L.C.J., van Rijn R.S.ORCID, Böhmer L.H., Ta B.D.P., Visser H.P.J.ORCID, Posthuma E.F.M., Bilgin Y.M.ORCID, Muller K., van Kampen D., So-Osman C.ORCID, Vermaat J.S.P., de Weijer R.J., Kersten M.J., van Leeuwen F.E., Schaapveld M.
Funder
KWF Kankerbestrijding
|
|